Product
Manufacture Facilities
To be a leading company in veterinary vaccine business, we have Value Creation Division and operate GMP facility for vaccine manufacture.
CTCVAC’s value creation is the process of turning our technologies and resources into high-quality vaccine products that meet global standards, with our key experts in the field of production.
The GMP facility is located in an exclusive and EU/US GMP guideline applied building with 5,958 sq.
mt. area spread over three floors. It is capable of manufacture all kinds of veterinary vaccines, has cultivation system for various antigens and is
currently in production of various vaccine products.
- Purpose - Manufacture of Veterinary Vaccine (Swine, Poultry, Bovine, Fishery and Canine)
- Completion - Dec 2015, EU/US GMP Guidelines applied
- Total building Floor area of - 5,958 m2
- Capacity - Antigen Bulk - Egg, Cell, and Bacteria Culture
Finished Products - Live vaccine, Killed vaccine and Recombinant vaccine - Automation - Building Management System(BMS)
Environment Monitoring System(EMS)